The method, reported in the November issue of Nature Biotechnology, could lead to safe and
effective human gene therapies for cystic fibrosis, hemophilia, and a variety of other diseases.
The principles that have emerged thus far are these: We should seek new knowledge of our
genes (and we can say this without deciding whether the
Human Genome Initiative is the wisest and most cost -
effective way to do so) We should seek
therapies for the genetic disorders that afflict many people.